Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 3
Submit an article Journal homepage
892
Views
11
CrossRef citations to date
0
Altmetric
Research Papers

Do Australian immunoglobulin products meet international measles antibody titer standards?

Megan K. YoungSchool of Medicine and Menzies Health Institute Queensland, Griffith University, Gold Coast, AustraliaCorrespondence[email protected]
,
Joseph BertoliniCSL Behring (Australia) Pty Ltd, Broadmeadows, Australia
,
Pushpa KotharuCSL Behring (Australia) Pty Ltd, Broadmeadows, Australia
,
Darryl MaherCSL Behring (Australia) Pty Ltd, Broadmeadows, Australia
&
Allan W. CrippsSchool of Medicine and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia
Pages 607-612 | Received 09 Jun 2016, Accepted 06 Sep 2016, Published online: 23 Dec 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Megan K. Young. (2019) The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles. Human Vaccines & Immunotherapeutics 15:9, pages 2060-2065.
Read now
Paul A. Gastañaduy, Emily Banerjee, Chas DeBolt, Pamela Bravo-Alcántara, Samia A. Samad, Desiree Pastor, Paul A. Rota, Manisha Patel, Natasha S. Crowcroft & David N. Durrheim. (2018) Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Human Vaccines & Immunotherapeutics 14:9, pages 2222-2238.
Read now
Megan K Young, Shu-Kay Ng, Graeme R Nimmo & Allan W Cripps. (2018) The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended. Expert Opinion on Drug Metabolism & Toxicology 14:7, pages 663-669.
Read now

Articles from other publishers (8)

Benno Kohlmaier, Heidemarie Holzmann, Karin Stiasny, Manuel Leitner, Christoph Zurl, Volker Strenger, Michael Kundi & Werner Zenz. (2021) Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants. Frontiers in Pediatrics 9.
Crossref
Alexandra Serra, Núria Marzo, Berta Pons, Pau Maduell, Maite López & Salvador Grancha. (2021) Characterization of antibodies in human immunoglobulin products from different regions worldwide. International Journal of Infectious Diseases 104, pages 610-616.
Crossref
Leanne Philips, Megan K Young, Janet Wallace & Hazel C Dobinson. (2020) Clinical experience of intramuscular immunoglobulin for measles prophylaxis in children: Is it practical?. Journal of Paediatrics and Child Health 56:3, pages 364-366.
Crossref
John W Sleasman, William R Lumry, Iftikhar Hussain, H James Wedner, James B Harris, Kecia L Courtney, Elsa Mondou, Jiang Lin & Mark R Stein. (2019) Immune globulin subcutaneous, human – klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study. Immunotherapy 11:16, pages 1371-1386.
Crossref
Jeungwoon Hong, Daegeun Kim, Younhee Won, Jungsoon Yoon, Kuk Jin Park, Jaetaek Oh & Chan-Wha Kim. (2019) Correlation between the results of two analytical methods for measuring measles virus neutralizing antibodies in source plasma and therapeutic immunoglobulin products. Biologicals 59, pages 20-28.
Crossref
Megan K Young, Allan W Cripps & Graeme R Nimmo. (2019) The use of normal human immunoglobulin (NHIG) for public health purposes in Queensland 2004-2014 and Australia 2014-2016. Communicable Diseases Intelligence 43.
Crossref
Dorothea Matysiak-Klose, Sabine Santibanez, Christine Schwerdtfeger, Judith Koch, Horst von Bernuth, Hartmut Hengel, Martina Littmann, Martin Terhardt, Sabine Wicker, Annette Mankertz & Ulrich Heininger. (2018) Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany. Vaccine 36:52, pages 7916-7922.
Crossref
Peter J. Späth. 2018. Antibody Therapy. Antibody Therapy 175 202 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.